Luis Eduardo Caroli, CEO of BioZeus, is contributing to the pre-commercial development of Brazilian-born innovations. In this interview he explains how he set up the company and documents the company’s unique model of collaboration between local project managers and highly experienced senior international executives to develop academic science, as well as the products he is looking to license to large multinational companies in the years to come.
Could you tell our readers about your career and how you became CEO of BioZeus?
"The ultimate goal of our investment is to license the production and commercialization of our products to pharmaceutical companies."
